Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-22-063020

Chief Financial Officer sold 30,625 shares at $40.00 ($1,225,000)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Myszkowski Kenneth Allen Chief Financial Officer 2022-12-29 Sale −30,625 $40.00 $1,225,000 336,704 D
Open-market sales · 30,625 sh · avg $40.00 · $1,225,000
Loading xslF345X03/doc4.xml…